Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03490097

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03490097
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03490097. Randomized; double masking; primary purpose treatment. Start 2017-12-01 (actual); primary completion 2018-05-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination
Condition
Chronic Hepatitis c
Intervention (Drug)
Simvastatin 10mg
Intervention (Drug)
sofosbuvir plus daclatasvir
Lead sponsor
Ain Shams University (class: other)

Record details

Record id
cardio:ct-nct03490097
Content hash
4a856328e96952ffe0edc35268d1a29367c70c759ef533021bc6ec029bf7243d